Paper41508380
Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men.
Clift AK and 3 others. World J Mens Health, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men. Papers, record 41508380. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41508380
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Real-World Outcomes and Safety of Testosterone Therapy: A Longitudinal, Retrospective Cohort Study of Over 9,000 Men.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15713727 | Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. | J Clin Endocrinol Metab | 2005 | https://conductscience.org/library/papers/15713727 | PubMed |
| 2 | 31351915 | Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine. | Sex Med Rev | 2019 | https://conductscience.org/library/papers/31351915 | PubMed |
| 3 | 20554979 | Identification of late-onset hypogonadism in middle-aged and elderly men. | N Engl J Med | 2010 | https://conductscience.org/library/papers/20554979 | PubMed |
| 4 | 36282060 | What Is a Normal Testosterone Level for Young Men? Rethinking the 300 ng/dL Cutoff for Testosterone Deficiency in Men 20-44 Years Old. | J Urol | 2022 | https://conductscience.org/library/papers/36282060 | PubMed |
| 5 | 12747807 | The Aging Males' Symptoms (AMS) scale: update and compilation of international versions. | Health Qual Life Outcomes | 2003 | https://conductscience.org/library/papers/12747807 | PubMed |
| 6 | 34694927 | Comparison of Outcomes for Hypogonadal Men Treated with Intramuscular Testosterone Cypionate versus Subcutaneous Testosterone Enanthate. | J Urol | 2022 | https://conductscience.org/library/papers/34694927 | PubMed |
| 7 | 19564179 | Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. | BMJ | 2009 | https://conductscience.org/library/papers/19564179 | PubMed |
| 8 | 40346275 | Testosterone replacement therapy and spermatogenesis in reproductive age men. | Nat Rev Urol | 2025 | https://conductscience.org/library/papers/40346275 | PubMed |
| 9 | 30427999 | Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. | JAMA Psychiatry | 2019 | https://conductscience.org/library/papers/30427999 | PubMed |
| 10 | 33586676 | Testosterone replacement in aging men: an evidence-based patient-centric perspective. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33586676 | PubMed |
| 11 | 25648342 | The efficacy of combination treatment with injectable testosterone undecanoate and daily tadalafil for erectile dysfunction with testosterone deficiency syndrome. | J Sex Med | 2015 | https://conductscience.org/library/papers/25648342 | PubMed |
| 12 | 35800844 | Efficacy and Safety of Human Chorionic Gonadotropin Monotherapy for Men With Hypogonadal Symptoms and Normal Testosterone. | Cureus | 2022 | https://conductscience.org/library/papers/35800844 | PubMed |
| 13 | 35711614 | Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis. | Lancet Healthy Longev | 2022 | https://conductscience.org/library/papers/35711614 | PubMed |
| 14 | 29772111 | Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study. | BJU Int | 2018 | https://conductscience.org/library/papers/29772111 | PubMed |
| 15 | 34445892 | The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials. | J Urol | 2022 | https://conductscience.org/library/papers/34445892 | PubMed |
| 16 | 30934591 | Evolution of Guidelines for Testosterone Replacement Therapy. | J Clin Med | 2019 | https://conductscience.org/library/papers/30934591 | PubMed |
| 17 | 29150464 | Testosterone therapy in hypogonadal men: a systematic review and network meta-analysis. | BMJ Open | 2017 | https://conductscience.org/library/papers/29150464 | PubMed |
| 18 | 19657348 | The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. | Int J Impot Res | 2010 | https://conductscience.org/library/papers/19657348 | PubMed |
| 19 | 38150256 | Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. | JAMA Netw Open | 2023 | https://conductscience.org/library/papers/38150256 | PubMed |
| 20 | 37804846 | Symptomatic benefits of testosterone treatment in patient subgroups: a systematic review, individual participant data meta-analysis, and aggregate data meta-analysis. | Lancet Healthy Longev | 2023 | https://conductscience.org/library/papers/37804846 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41508380
GET https://conductscience.org/api/papers/v1/41508380/references?page=2